Skip to main content

Center for Vaccine Development and Global Health (CVD)

Overview

Our faculty and staff are experts in the field of global health and vaccinology, and they are dedicated to improving global health by conducting innovative, world-leading research in Baltimore and around the world. Our key mission is to harness the power of vaccines to prevent disease and save lives in the most vulnerable populations.

Our research, surveillance and vaccine development focuses on four key areas: Enteric Diseases, Malaria, Influenza and Respiratory Diseases, and Emerging Pathogens.

For over 40 years, our researchers in the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM) in Baltimore, MD have worked domestically and internationally to develop, test, and deploy vaccines to aid the world’s underserved populations.

The CVD is an academic enterprise engaged in the full range of infectious disease intervention from basic laboratory research through vaccine development, pre-clinical and clinical evaluation, large-scale pre-licensure field studies, and post-licensure assessments.

Training is a critical component of our work to ensure the foundation for the next generation of scientists and researchers committed to global health initiatives.


Click Here for a full-screen map

GIVE TO CVD

VOLUNTEER FOR CVD TRIALS


Kathleen M. Neuzil, MD, MPH, FIDSA
Director, Center for Vaccine Development and Global Health


Connect with Us


News and Events

November 20, 2019

Two UM School of Medicine Experts Receive Prestigious 2019 Bailey K. Ashford Medal for Distinguished Work in Tropical Medicine

Dr. Shannon Takala-Harrison is a Leader in Malaria Research and Dr. Sharon Tennant is a Leader in Vaccine Research.


October 24, 2019

Dr. James Campbell Makes Baltimore Magazine’s 2019 “Top Docs” List

Dr. Campbell is a pediatric infectious disease specialist conducting important vaccine research


 

October 21, 2019

UM School of Medicine's Kathleen M. Neuzil Elected as Member of Prestigious National Academy of Medicine

Dr. Neuzil Has Played an Important Leadership Role in Bridging Science and Policy to Serve the World’s Most Vulnerable Populations


 

September 20, 2019

UM School of Medicine's Center for Vaccine Development and Global Health Receives NIH Contract of up to More than $200 Million for Influenza Research

Dr. Kathleen Neuzil to Lead Major Research Collaborative with Ultimate Goal of Protecting Millions Against Emerging Influenza Strains


 

September 10, 2019

Frontiers in Vaccinology

"Varicella Zoster Virus: Chickenpox, Shingles and Beyond" presented by Anne A. Gershon, MD, Columbia University Irving Medical Center


 

More News